HHS

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 47.63 M47.13 M41.56 M38.63 M39.52 M 166.84 M Gross profit 47.63 M47.13 M41.56 M38.63 M39.52 M 166.84 M Operating expenses 44.69 M20.52 M19.9 M17.94 M16.87 M 75.24 M Selling/general/admin expenses 5.26 M5.73 M5.84 M5.54 M5.15 M 22.26 M Research & development ————— — Operating income 1.9 M-1.55 M40 K34 K509 K -970 K Non-Operating Income, Total 888 K311 K567 K447 K190 K 1.51 M Interest expense, net of interest capitalized 9 00014 K15 K14 K13 K 56 K Non-Operating Income, excl. Interest Expenses 48 K-556 K38 K47 K71 K -400 K Unusual income/expense 831 K853 K514 K386 K106 K 1.86 M Pretax income 1.01 M-156 K607 K413 K319 K 1.18 M Equity in earnings ————— — Taxes 900 K-2.36 M200 K100 K2.6 M 537 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 142 K2.15 M392 K335 K2.29 M 5.16 M Discontinued operations ————— — Net income 142 K2.15 M392 K335 K2.29 M 5.16 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 142 K2.15 M392 K335 K2.29 M 5.16 M Basic earnings per share (Basic EPS) 0.02-0.31-0.05-0.05-0.31 -0.72 Diluted earnings per share (Diluted EPS) 0.02-0.31-0.05-0.05-0.31 -0.72 Average basic shares outstanding 7.32 M7.29 M7.36 M7.38 M7.42 M 29.45 M Diluted shares outstanding 7.4 M7.29 M7.36 M7.38 M7.42 M 29.45 M EBITDA -43.47 M27.88 M22.72 M21.76 M23.86 M 96.23 M EBIT 2.94 M26.61 M21.66 M20.69 M22.65 M 91.61 M Cost of revenue 00000 0 Other cost of goods sold 00000 0 Depreciation & amortization (cash flow) 1.04 M1.28 M1.06 M1.06 M1.22 M 4.62 M